Christopher R. Loose, Chief Scientific Officer at Frequency Therapeutics, Inc. (FREQ), sold 2,610 shares at $0.37 ($953) on 2023-07-10, disclosed to the SEC on 2023-07-12.
Scheduled sale ($953) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.36 | 1,306 | $470 | 49.4% |
| 2 | $0.37 | 1,304 | $482 | 50.6% |
| Total | $0.36 avg | 2,610 | $953 | 100% |
| Filing → |
| FREQ | SELL | 2023-07-25 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-21 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-19 | $2K | — | Filing → |